Grants and Contributions

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

The specific objectives of this funding opportunity are to:

• Address the biological, social, environmental and/or behavioural effects on lung health through rigorous research approaches informed by intersectional analyses;
• Coordinate the collection and sharing of data to understand, prevent, detect and manage lung health to improve reproducibility and rigour of research results;
• Disseminate, inform and implement high-quality evidence into practice and policy for improved and more equitable health outcomes;
• Strengthen and promote lung health research capacity through interdisciplinary and experiential-based approaches to foster the next generation of lung health researchers;
• Meaningfully integrate equity, diversity and inclusion analyses and considerations within research studies and teams;
• Broadly strengthen the respiratory health and wellness of people living in Canada with meaningful consideration of historically excluded groups and Indigenous Peoples (First Nations, Inuit, and Métis).

The specific objectives of this funding opportunity are to:

• Address the biological, social, environmental and/or behavioural effects on lung health through rigorous research approaches informed by intersectional analyses;
• Coordinate the collection and sharing of data to understand, prevent, detect and manage lung health to improve reproducibility and rigour of research results;
• Disseminate, inform and implement high-quality evidence into practice and policy for improved and more equitable health outcomes;
• Strengthen and promote lung health research capacity through interdisciplinary and experiential-based approaches to foster the next generation of lung health researchers;
• Meaningfully integrate equity, diversity and inclusion analyses and considerations within research studies and teams;
• Broadly strengthen the respiratory health and wellness of people living in Canada with meaningful consideration of historically excluded groups and Indigenous Peoples (First Nations, Inuit, and Métis).

• Accelerate and facilitate dissemination of evidence-based information through an inventory function to provide equitable and inclusive access to research findings to diverse audiences across Canada, promoting health literacy.
• Contribute to the dissemination of the knowledge created by research in areas related to the National Dementia Strategy
• Foster impactful, equitable and accessible uptake of knowledge (including official language considerations) created through research, to inform policy development and/or promote implementation of evidence-based interventions.
• Increase collaborations and create linkages between a diversity of researchers and knowledge users in the brain health and cognitive impairment in aging field, including partners in research (e.g., Indigenous communities), and the public.

The Lindau Nobel Laureate Meetings help promote science and research by fostering the exchange of knowledge, ideas, and experience between and among Nobel Laureates, scientists of different generations, cultures, and disciplines.

The Secretariat on Responsible Conduct of Research (SRCR), in conjunction with the Panel on Research Ethics (PRE) and the Panel on Responsible Conduct of Research (PRCR), administer a grant program to support events that complement their mandate to promote research ethics and the responsible conduct of research.

The Secretariat on Responsible Conduct of Research (SRCR), in conjunction with the Panel on Research Ethics (PRE) and the Panel on Responsible Conduct of Research (PRCR), administer a grant program to support events that complement their mandate to promote research ethics and the responsible conduct of research.

Objectives
The overarching objective of this funding opportunity is to support key databank activities to enable
secondary analyses on COVID-19 immunity data housed in the databank created by the COVID-19
Immunity Task Force (CITF). This will allow for the uncovering of novel findings through
interdisciplinary and intersectoral analysis on Canada’s COVID experience and will provide valuable
insights towards future pandemics and emergency management. This objective will be achieved through
all the following specific activities:
1. Curation, organization, harmonization, and visualization of incoming data;
2. Development and maintenance of data dashboards;
3. Encourage and promote use of data and the mobilization of knowledge;
4. Management of data requests and provision of data to researchers and/or policy makers;
5. Enable secondary analyses through the maintenance of data access infrastructure (Data Access
Office and Data Access Committee) and ensure open access; and
6. Undertake requests for assistance with analysis (statistical consulting), custom tabulation for
modellers or other methodologic work, as appropriate.

The specific objectives of this funding opportunity are to:

• Increase and advance the development of gene therapies for rare disease clinical trials in Canada;
• Generate the evidence required for first-in-human clinical trials, in part by working with Canada’s biomanufacturing capacity (National Research Council of Canada) and health technology regulator (Health Canada); and,
• Increase current and future capacity across the Canadian rare disease landscape (i.e., among researchers, knowledge users, patient(s)/caregiver(s)/family) to improve readiness of gene therapies for first-in-human clinical trials.

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment